Short Interest in Azitra, Inc. (NYSEAMERICAN:AZTR) Rises By 177.1%

Azitra, Inc. (NYSEAMERICAN:AZTR) was the recipient of a significant growth in short interest in March. As of March 13th, there was short interest totaling 343,444 shares, a growth of 177.1% from the February 26th total of 123,961 shares. Based on an average daily trading volume, of 1,772,449 shares, the short-interest ratio is presently 0.2 days. Currently, 2.1% of the shares of the company are sold short.

Azitra Stock Up 1.7%

AZTR stock traded up $0.00 during midday trading on Friday, hitting $0.24. 4,845,627 shares of the stock traded hands, compared to its average volume of 13,078,057. Azitra has a 1-year low of $0.10 and a 1-year high of $2.66. The stock’s fifty day simple moving average is $0.22 and its 200-day simple moving average is $0.40.

About Azitra

Azitra Inc is a clinical-stage biopharmaceutical company focused on developing live bacterial therapies for dermatological conditions. Headquartered in Cambridge, Massachusetts, the company leverages its proprietary ActoBiotic platform to formulate topical treatments that aim to modulate the skin’s native microbial ecosystem.

The company’s lead investigational therapies are being evaluated in early-phase clinical studies for inflammatory skin disorders, including atopic dermatitis and other conditions characterized by microbial imbalance.